Verified

Innovators Award

Marfan Foundation

This is for faculty investigators for $100,000 over 2 years ($50,000 per year), to explore an innovative concept in “translational” science that has applicability to improving human health. Examples could include fundamental research, diagnostic tests, biomarkers, biomedical engineering advances, and imaging advances. Collection of data for improved evidence-based medical guidance are of great interest.

Deadlines:

Application Due: October 19, 2026

Award Announcement: April 29, 2027

Funding Available: July 1, 2027

AI Based Application Success Predictor

1. ⭐⭐⭐⭐⭐ Direct relevance to Marfan syndrome and genetic aortic/vascular disease

This is the most important predictor.

The Foundation explicitly funds research in Marfan syndrome, LDS, VEDS and related genetic aortic and vascular conditions.

A strong proposal should clearly explain:

Which genetic aortic/vascular condition is being studied.
The specific disease problem.
The biological or clinical knowledge gap.
Why solving that gap matters to affected patients.
How the results could improve diagnosis, treatment, prevention or quality of life.

Recent awards demonstrate that the Foundation supports research across Marfan and related aortopathies rather than limiting funding exclusively to FBN1 biology.

High-value framing:

Genetic aortopathy problem → specific mechanism/risk factor → testable intervention or diagnostic strategy → improved patient outcome.

2. ⭐⭐⭐⭐⭐ Potential to prevent aortic aneurysm, dissection or other life-threatening complications

Aortic disease is a central clinical problem in Marfan syndrome and related genetic aortopathies.

The Foundation's recent portfolio includes research on:

Aortic aneurysm formation.
Aortic dissection.
Aortic rupture.
Aortic wall vulnerability.
Aortic biomechanics.
Smooth-muscle-cell function.
Inflammatory mechanisms.
Therapeutic approaches to strengthen the aorta.

Projects that can improve risk prediction, early detection, prevention or treatment of aortic disease therefore have particularly strong alignment with the Foundation's research mission.

3. ⭐⭐⭐⭐⭐ Innovative / transformational scientific concept

The Foundation explicitly describes its research program as pursuing innovative research, and its Innovators Award supports innovative concepts with potential to improve human health.

Examples of recent innovative directions include:

AAV-Perturb-Seq to identify novel therapeutic targets.
Senolytic approaches to aneurysm therapy.
Targeted nanopolymers for aortic repair.
Multiomic identification of biomarkers.
Aorta-on-a-chip technology.
Machine learning for aortic dissection markers.

Thus, innovation can arise from either:

New biological mechanism

New technology/methodology

New therapeutic/diagnostic strategy.

4. ⭐⭐⭐⭐⭐ Clear translational pathway toward better patient outcomes

The Foundation's stated research goal is to improve diagnosis, treatment, care, health outcomes and quality of life for people with genetic aortic and vascular conditions.

A strong proposal should explain the eventual pathway:

Basic discovery
↓
Mechanistic validation
↓
Biomarker/therapeutic target
↓
Preclinical or clinical validation
↓
Improved diagnosis/treatment/prevention

This does not mean every project must already be close to clinical implementation. The Foundation funds fundamental research as well. The important point is that the applicant should explain why the discovery could ultimately matter to patients.

5. ⭐⭐⭐⭐⭐ Strong scientific rigor and testable research plan

The Foundation's Scientific Advisory Board reviews proposals, followed by approval from the Board of Directors.

A competitive application should therefore demonstrate:

Clear hypothesis or research question.
Strong scientific rationale.
Appropriate models.
Appropriate controls.
Robust methodology.
Appropriate statistical analysis.
Clearly defined outcomes.
Alternative approaches for major technical risks.
A realistic timeline.

For mechanistic studies, reviewers should be able to see exactly how the proposed experiments will establish causality rather than merely correlation.

6. ⭐⭐⭐⭐☆ Strong potential to generate preliminary data for larger funding

This is particularly important for the Career Development Award.

The Foundation explicitly states that the Career Development Award is intended to help early-career investigators obtain preliminary data in a key concept area with potential to lead to extended funding from NIH, the EU or other large funding sources.

Therefore, an excellent Career Development proposal should answer:

What critical data will this $100,000 award generate that will allow the investigator to compete for substantially larger external funding?

The project should function as a launchpad, not simply as a stand-alone small study.

7. ⭐⭐⭐⭐☆ Strong investigator development and independence

Career development is an explicit component of the Foundation's portfolio.

The Victor McKusick Fellowship is designed for postdoctoral fellows beginning scientific careers in biomedical research related to Marfan syndrome and related conditions. Fellows are expected to work with mentors in a research environment that provides appropriate training.

The Foundation's historical fellowship guidance emphasizes training in:

Research methodology.
Biomedical statistics.
Research design.
Grant writing.
Regulatory/ethical issues.
Independent research skills.

The intended outcome is preparation for an independent research career and competitive extramural funding.

8. ⭐⭐⭐⭐☆ Use of modern molecular, imaging, engineering or computational approaches

The Foundation's current Innovators Award specifically lists areas such as:

Basic science.
Clinical research.
Diagnostic tests.
Biomarkers.
Biomedical engineering.
Imaging advances.

The funded portfolio confirms that advanced methods are being used, including:

Multiomics.
Single-cell approaches.
Machine learning.
Aorta-on-a-chip.
Nanotechnology.
Advanced imaging.
Gene-based approaches.

This does not mean that a proposal needs sophisticated technology. Rather, technology should be used when it materially improves the ability to answer an important genetic-aortopathy question.

9. ⭐⭐⭐⭐☆ Feasibility and appropriate scope

Marfan Foundation awards are relatively targeted:

Innovators Award: $100,000 over 2 years.
Career Development Award: $100,000 over 2 years.
Victor McKusick Fellowship: $100,000 for PhD / $150,000 for MD over 2 years.

A successful project therefore needs to accomplish something meaningful within its funding period.

Strong applications should demonstrate:

Existing infrastructure.
Required models or patient samples.
Qualified collaborators.
Appropriate technical expertise.
Realistic recruitment.
Achievable milestones.
A focused number of Specific Aims.

10. ⭐⭐⭐⭐☆ Alignment with the appropriate grant mechanism and career stage

The Foundation currently offers different mechanisms for different stages and objectives:

Mechanism	Primary purpose
Innovators Award	Innovative concepts with potential to improve human health
Career Development Award	Early-career investigator + preliminary data + future major funding
Victor McKusick Fellowship	Postdoctoral research career development
Everest Award	Larger, multidisciplinary, collaborative transformational research

The Foundation's 2022 announcement described the Everest Award as a mechanism for longer, multidisciplinary and collaborative grants aimed at transformational science and cures.

Therefore:

Scientific quality + wrong mechanism = reduced fit.

Specialties

Genetics & Genomics

Eligibility Requirements

The principal investigator must hold an MD, DO, PhD, ScD, DDS, DVM, or equivalent degree. The investigator must have a proven ability to pursue independent research, as evidenced by original research publications in peer-reviewed journals. The award is designed to support investigators studying any discipline. Work can be performed in the U.S. or internationally, and non-U.S. appointments are acceptable.

Sponsor Details

Sponsor Institute/Organizations: Marfan Foundation

Sponsor Type: Corporate/Non-Profit

Address: 22 Manhasset Avenue Port Washington, NY 11050

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity